Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | GMNN | O75496 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.60 |
| ▸ | PPARG | P37231 | 7/20 | 0.60 |
| ▸ | PPARD | Q03181 | 7/20 | 0.60 |
| ▸ | PPARA | Q07869 | 7/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624892 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL1603644 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL28388081 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL28905473 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL9262447 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL9185714 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL8865660 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL9015776 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL1527381 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL11465686 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107261148-A | Methylphenidate prodrug, its preparation and application | 凯姆制药公司 | 2017-10-20 | — | — | CN | claimed |
| EP-2736510-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | Kempharm, Inc. (US) | 2014-06-04 | — | — | EP | claimed |
| CN-103826633-A | Methylphenidate prodrugs, methods of making and using the same | KEMPHARM INC | 2014-05-28 | — | — | CN | claimed |
| WO-2013016668-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | KEMPHARM INC. (US) | 2013-01-31 | — | — | WO | claimed |
| CN-122055347-A | Oligomeric binaphthyl compounds and thermoplastic resins | 三菱瓦斯化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-20260070867-A1 | BINAPHTHYL COMPOUNDS AND THERMOPLASTIC RESINS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-12 | — | — | US | disclosed |
| CN-114752053-B | Polycarbonate resin, method for producing same, and optical lens | 三菱瓦斯化学株式会社 | 2025-05-30 | — | — | CN | disclosed |
| CN-115960345-B | Polycarbonate resin, method for producing same, and optical lens | 三菱瓦斯化学株式会社 | 2025-05-06 | — | — | CN | disclosed |
| US-20250032479-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ZEVRA THERAPEUTICS INC (US) | 2025-01-30 | — | — | US | disclosed |
| CN-114716658-B | Polycarbonate resin, method for producing same, and optical lens | 三菱瓦斯化学株式会社 | 2024-12-31 | — | — | CN | disclosed |
| CN-119137185-A | Oligomeric binaphthyl compounds and thermoplastic resins | 三菱瓦斯化学株式会社 | 2024-12-13 | — | — | CN | disclosed |
| EP-0910633-A2 | POLYKETIDES AND THEIR SYNTHESIS | Biotica Technology Limited (GB) | 1999-04-28 | — | — | EP | disclosed |
| WO-1998001546-A2 | POLYKETIDES AND THEIR SYNTHESIS | BIOTICA TECHNOLOGY LIMITED (GB) | 1998-01-15 | — | — | WO | disclosed |
| EP-0559898-B1 | ANILIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 1996-05-08 | — | — | EP | disclosed |
| US-5475130-A | A thio, sulfonyl, sulfoxidyl or sulfonate acetamide compound as enzyme inhibitor of acyl-coenzyme A cholesterol acyltransferase | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1995-12-12 | — | — | US | disclosed |
| CN-1082534-A | Alkan amido ammonium compound | TAISHO PHARMACEUTICAL CO LTD (JP) | 1994-02-23 | — | — | CN | disclosed |
| EP-0559898-A1 | ANILIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1993-09-15 | — | — | EP | disclosed |
| US-4298520-A | PHOSPHITES OR PHOSPHATES | ARGUS CHEMICAL CORP. (US) | 1981-11-03 | — | — | US | disclosed |
| US-4171298-A | SUBSTITUTED ORTHO-ALKYLHYDROXYBENZYLPROPANE-1,3-DIOL ESTERS | ARGUS CHEMICAL CORPORATION (US) | 1979-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032479-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRL1, OPRK1 | HSD17B10 1055/4885MAPT 2544/4885GMNN 2449/4885 |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | SLC16A3, SLC16A8, SLC16A1 | HSD17B10 133/4885MAPT 2316/4885GMNN 4409/4885 |
| US-20260070867-A1 | BINAPHTHYL COMPOUNDS AND THERMOPLASTIC RESINS | CBR1, CBR3, SCO2 | HSD17B10 990/4885MAPT 4394/4885GMNN 2811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.